{"title":"Cambios del estado clínico periodontal según consumo sistémico de estatinas","authors":"David Rosenberg , Catherine Andrade , Ricardo Larrea , Alejandra Chaparro , Carolina Inostroza , Valeria Ramirez , Cinthya Urquidi , Deborah Violant , José Nart","doi":"10.1016/j.piro.2015.03.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To describe changes in periodontal clinical status of patients according to systemic statin use prescribed by a cardiologist.</p></div><div><h3>Material and methods</h3><p>A descriptive study was performed on patients with chronic periodontitis referred from the Department of Cardiovascular Diseases of Dávila Clinic. A group of them began statin therapy. Clinical measurements of periodontal probing depth (PD), clinical attachment level, bleeding index, periodontal inflamed surface area, and gingival index, were performed at baseline (before starting statin therapy) and 6 months later. Data were analyzed using descriptive statistics.</p></div><div><h3>Results</h3><p>A total of 10 patients participated in the study, and five of them received statin therapy. The statin group compared to the group without statins, showed a mean decrease in: PD (0.4<!--> <!-->mm versus 0.13<!--> <!-->mm); percentage of PS sites<!--> <!-->≥<!--> <!-->5<!--> <!-->mm (4.16% versus 1.09%); clinical attachment level (0.5<!--> <!-->mm versus 0.2<!--> <!-->mm), bleeding index (27.16% versus 8.8%), and periodontal inflamed surface area (305.68 versus 121.35 mm<sup>2</sup>).</p></div><div><h3>Conclusions</h3><p>These results suggest that patients with chronic periodontitis may benefit from systemic therapy with statins. Randomized clinical trials with optimal sample size are required to check the effect and impact of statins on the periodontal status.</p></div>","PeriodicalId":21203,"journal":{"name":"Revista clínica de periodoncia, implantología y rehabilitación oral","volume":"8 2","pages":"Pages 111-116"},"PeriodicalIF":0.0000,"publicationDate":"2015-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.piro.2015.03.005","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista clínica de periodoncia, implantología y rehabilitación oral","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0718539115000397","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To describe changes in periodontal clinical status of patients according to systemic statin use prescribed by a cardiologist.
Material and methods
A descriptive study was performed on patients with chronic periodontitis referred from the Department of Cardiovascular Diseases of Dávila Clinic. A group of them began statin therapy. Clinical measurements of periodontal probing depth (PD), clinical attachment level, bleeding index, periodontal inflamed surface area, and gingival index, were performed at baseline (before starting statin therapy) and 6 months later. Data were analyzed using descriptive statistics.
Results
A total of 10 patients participated in the study, and five of them received statin therapy. The statin group compared to the group without statins, showed a mean decrease in: PD (0.4 mm versus 0.13 mm); percentage of PS sites ≥ 5 mm (4.16% versus 1.09%); clinical attachment level (0.5 mm versus 0.2 mm), bleeding index (27.16% versus 8.8%), and periodontal inflamed surface area (305.68 versus 121.35 mm2).
Conclusions
These results suggest that patients with chronic periodontitis may benefit from systemic therapy with statins. Randomized clinical trials with optimal sample size are required to check the effect and impact of statins on the periodontal status.